Theraclone Sciences' Partnership

Theraclone Sciences raised a round of funding on October 13, 2009. Investors include Zenyaku Kogyo.

Theraclone Sciences, formerly Spaltudaq, is a biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The companys technolo…

Articles about Theraclone Sciences' Partnership: